Insiders

02-13 Olympus Corporation Announces Change of Executive Officer, Effective April 1, 2026 CI
02-12 Oryzon Genomics, S.A. Announces Chief Medical Officer For CNS Programs Changes CI
02-09 NervGen Pharma Corp. Appoints Adam Rogers as President, Effective February 9, 2026 CI
02-09 NervGen Pharma Corp. Appoints Adam Rogers as Chief Executive Officer, Effective February 9, 2026 CI
02-05 IXICO plc Appoints Tanya Voloshen as Chief Commercial Officer CI
02-04 Freshpet, Inc. Announces Appointment of Ana Lopez as Senior Vice President of Supply Chain, Effective February 2, 2026 CI
02-03 Rigel Pharmaceuticals, Inc. Appoints Michael P. Miller to Its Board of Directors CI
02-02 STAAR Surgical Company Announces Interim Co-CEO Appointments, Effective February 1, 2026 CI
01-29 Johnson & Johnson Insider Sold Shares Worth $22,122,893, According to a Recent SEC Filing MT
01-28 BioNTech SE Announces Appointment of Kylie Jimenez to the Management Board as Chief People Officer, Effective March 1, 2026 CI
01-19 MediPharm Labs CEO David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO MT
01-19 Medipharm Labs Corp. Announces CEO Changes, Effective January 23, 2026 CI
01-15 N.Y. Attorney General Sues Former Emergent Biosolutions CEO for Insider Trading -- Update DJ
01-15 N.Y. Attorney General Sues Former Emergent Biosolutions CEO for Insider Trading DJ
01-14 BD Appoints Shawn Bevec as Senior Vice President of Investor Relations, Effective January 20, 2026 CI
01-12 Outset Medical, Inc. Announces Board Changes CI
01-09 PRESS DIGEST-Wall Street Journal - January 9 RE
01-08 Xilio Therapeutics, Inc. Announces Change of Chair of the Board of Directors CI
01-08 Jasper Therapeutics, Inc. Announces Executive Changes CI
01-08 Jasper Therapeutics, Inc. Announces Chief Executive Officer Changes CI
01-07 Palvella Therapeutics, Inc. Appoints Vimal Patel as Senior Vice President of Medical Affairs CI
01-06 LB Pharmaceuticals, Inc Announces Appointment of Ellen Rose as Senior Vice President, Corporate Affairs and Lindsay Beaupre as Senior Vice President, People and Culture CI
01-05 Orum Therapeutics Appoints Chad May as Chief Scientific Officer CI
12-16 S&P Global Appoints Hubert Joly to the Board of Directors and Member of Audit and Compensation and Leadership Development Committees, Effective January 2, 2026 CI
12-15 The Hain Celestial Group, Inc. Appoints Alison E. Lewis as President, Effective December 15, 2025 CI
No results for this search